Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bor-Sheng Ko

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.
Blood|April 7, 2010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring systemHsin-An Hou, Tai-Chung Huang, Liang-In Lin, et al.
American Journal of Hematology|April 12, 2014
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
European Journal of Haematology|April 7, 2018
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
Blood Cancer Journal|March 13, 2026
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus ClassificationWan-Hsuan Lee, Hsin-An Hou, Chien-Chin Lin, et al.
Blood Cell Therapy|January 30, 2023
Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 2017 from APBMTMinako Iida, Kaiyan Liu, Xiao Jun Huang, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Ebiomedicine|October 27, 2018
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, et al.
Blood|August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsWen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Blood Research|December 26, 2025
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromesWan-Hsuan Lee, Chien-Chin Lin, Xavier Cheng-Hong Tsai, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.
Blood|April 7, 2010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring systemHsin-An Hou, Tai-Chung Huang, Liang-In Lin, et al.
American Journal of Hematology|April 12, 2014
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
European Journal of Haematology|April 7, 2018
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
Blood Cancer Journal|March 13, 2026
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus ClassificationWan-Hsuan Lee, Hsin-An Hou, Chien-Chin Lin, et al.
Blood Cell Therapy|January 30, 2023
Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 2017 from APBMTMinako Iida, Kaiyan Liu, Xiao Jun Huang, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Ebiomedicine|October 27, 2018
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, et al.
Blood|August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsWen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Blood Research|December 26, 2025
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromesWan-Hsuan Lee, Chien-Chin Lin, Xavier Cheng-Hong Tsai, et al.
Pageof 16